Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P840062/S099

CollaCote, CollaTape, CollaPlug, Absorbable Collagen Wound Dressings for Dental Surgery

Integra Lifesciences Corp. · Decision date Sep 18, 2026

MEDTECHLEDGER EXPLANATIONP840062/S099

What did the FDA decide?

The supplied record identifies PMA supplement P840062/S099 for Integra Lifesciences Corp. under product code LPG, in the Dental specialty, with the device category listed as a surgical dressing material. It is a 30-Day Notice with the reason given as a process change affecting manufacturer, sterilizer, packager or supplier, and its decision is recorded as OK30 with a date of 2026-09-18.

The source statement describes the reported change as installation and qualification of a new Water for Injection pretreatment, generation, storage, and distribution system. The record does not state where the system sits in the manufacturing flow, which dressing products it affects, or what qualification criteria were applied, so those details are absent rather than implied. The identifier links this filing to the original PMA P840062, but a supplement is not a new approval of the whole system, and the reported purpose does not by itself establish safety or clinical effectiveness.

FDA approval order statement

installation and qualification of a new Water for Injection (WFI) pretreatment, generation, storage, and distribution system
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Dental
Decision date
Sep 18, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P840062/S099
Regulatory pathway
PMA supplement
Product code
LPG
Decision code
OK30
Decision date
Sep 18, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: MATERIAL, DRESSING, SURGICAL, POLYLACTIC ACID.

Product code
LPG
FDA device class
3

For the original device and its historical approval scope, see PMA P840062. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P840062/S099 received

    Application receipt date recorded by FDA.

  2. P840062/S099 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P840062. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P840062

Product / regulatory recordCompanyPathwayDecision dateSource
Integra Lifesciences Corp.PMA approvalNov 8, 1985FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Integra Lifesciences Corp.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
311 Enterprise Dr., Planisboro, NJ, 08536

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records